Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2

Status

Unknown 2

Sponsor Class

OTHER 47INDUSTRY 12NIH 10OTHER_GOV 2NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 12Breast 6Other hematologic neoplasm 5Plasma cell 4Other solid neoplasm 2Myeloid 2Sarcoma 1Head & Neck 1Dermatologic 1

Conditions

Solid Tumors 1Solid Tumor 1

Interventions

pembrolizumab 2fludarabine 2apatinib 2Interleukin-2 2Cyclophosphamide 2spartalizumab 1phosphorylethanolamine 1olaparib 1liposomal doxorubicin 1ivarmacitinib 1camrelizumab 1anlotinib 1Valproic Acid 1Topotecan 1Talc 1Pharmaceutical Services 1Injections 1Hydralazine 1Cisplatin 1Cerebral Decortication 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Cyclophosphamide × Other solid neoplasm × Clear all
NCT05649618 2022-12-14

TIL Cells for the Treatment of the Advanced Solid Tumors Patients

Fujian Cancer Hospital

Phase EARLY_PHASE1 Unknown
42 enrolled
Other solid neoplasm

Solid Tumor

NCT05648994 2022-12-13

TCR-T Cells for the Treatment NY-ESO-1-positive Advanced Solid Tumors

Fujian Cancer Hospital

Phase EARLY_PHASE1 Unknown
30 enrolled
Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡